We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $1.59B
1-Year Est. Return 855.46%
This Fund
S&P 500
This Quarter Est. Return
+15.92%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
–
AUM
$271M
AUM Growth
-$32.2M
Cap. Flow
-$29.7M
Cap. Flow %
-10.95%
Top 10 Hldgs %
57.01%
Holding
64
New
15
Increased
2
Reduced
17
Closed
12

Top Buys

Rank Stock Value
1
APPS icon
Digital Turbine
APPS
+$9M
2
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$8.38M
3
BWEN icon
Broadwind
BWEN
+$4.26M
4
CVV icon
CVD Equipment Corp
CVV
+$3.77M
5
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$3.6M

Top Sells

Rank Stock Value
1
DZSI
DZS Inc. Common Stock
DZSI
+$14.6M
2
ASPN icon
Aspen Aerogels
ASPN
+$11.8M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$10.4M
4
EOLS icon
Evolus
EOLS
+$6.97M
5
INDI icon
indie Semiconductor
INDI
+$5.66M

Sector Composition

Rank Sector Weight
1 Technology 46.24%
2 Healthcare 42.24%
3 Industrials 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDNA
26
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$2.76M 1.02%
4,346,983
– –
THER
27
DELISTED
THERATECHNOLOGIES INC COM
THER
$2.75M 1.01%
3,408,434
-421,605
-11% -$340K
SPRB
28
Spruce Biosciences
SPRB
$129M
$2.37M 0.87%
+14,720
New +$2.73M
IPWR icon
29
Ideal Power
IPWR
$74.2M
$2.23M 0.82%
213,068
– –
COYA icon
30
Coya Therapeutics
COYA
$113M
$2.22M 0.82%
560,000
– –
YMAB
31
DELISTED
Y-mAbs Therapeutics
YMAB
$2.15M 0.79%
+428,412
New +$1.75M
OSA
32
DELISTED
ProSomnus, Inc. Common Stock
OSA
$2.04M 0.75%
390,640
– –
FKWL icon
33
Franklin Wireless
FKWL
$27M
$1.94M 0.72%
390,000
– –
ABEO icon
34
Abeona Therapeutics
ABEO
$413M
$1.84M 0.68%
652,174
– –
DM
35
DELISTED
Desktop Metal, Inc.
DM
$1.73M 0.64%
+75,000
New +$1.42M
NRDY icon
36
Nerdy
NRDY
$96.7M
$1.67M 0.62%
+400,000
New +$1.22M
APRE icon
37
Aprea Therapeutics
APRE
$7.83M
$1.53M 0.56%
+345,000
New +$2.55M
APYX icon
38
Apyx Medical
APYX
$171M
$1.51M 0.56%
+524,001
New +$1.53M
RVLP
39
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$1.43M 0.53%
1,256,393
-545,471
-30% -$655K
FENC icon
40
Fennec Pharmaceuticals
FENC
$402M
$1.35M 0.5%
+162,154
New +$1.5M
CLRB icon
41
Cellectar Biosciences
CLRB
$20.5M
$1.34M 0.49%
31,063
– –
MYO icon
42
Myomo
MYO
$56.2M
$1.2M 0.44%
+2,000,000
New +$1.17M
TFFP
43
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$1.19M 0.44%
69,565
– –
DFSC
44
DEFSEC Technologies
DFSC
$3.36M
$1.07M 0.4%
1,905
– –
BCDA icon
45
BioCardia
BCDA
$14.6M
$994K 0.37%
33,943
-5,739
-14% -$191K
SLNO
46
DELISTED
Soleno Therapeutics
SLNO
$904K 0.33%
422,489
– –
ADVM
47
DELISTED
Adverum Biotechnologies
ADVM
$861K 0.32%
120,000
– –
CGRN
48
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$816K 0.3%
613,903
-282,597
-32% -$497K
VCNX
49
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$380K 0.14%
4,532
-7,143
-61% -$785K
DFSC
50
CALL
DEFSEC Technologies
DFSC
$3.36M
$240K 0.09%
+2,852
New +$1.59M
1
2
3

Similar funds

VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

AIGH Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, AIGH Capital Management held 64 positions worth $271M, down 11% from $304M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

AIGH Capital Management withdrew a net $29.7M in Q1 2023, closing 12 positions and reducing 17 holdings. Its most notable exit was Aspen Aerogels, an estimated $11.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 47% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AIGH Capital Management opened a new position in Digital Turbine worth $8.28M.

  • AIGH Capital Management's largest Q1 2023 buy was Digital Turbine: 670,045 shares worth $8.28M.
  • AIGH Capital Management added most to CTI BioPharma Corp. (DE) Common Stock in Q1 2023, an estimated $3.6M increase.
  • AIGH Capital Management's biggest Q1 2023 reduction was DZS Inc. Common Stock, cutting an estimated $14.6M.
  • AIGH Capital Management fully exited Aspen Aerogels in Q1 2023, selling an estimated $11.8M.
  • AIGH Capital Management's ten largest holdings make up 57% of its $271M portfolio in Q1 2023.
  • AIGH Capital Management opened 15 new positions and closed 12 in Q1 2023.
  • AIGH Capital Management's portfolio value fell 11% quarter-over-quarter to $271M.

Based on AIGH Capital Management's 13F filing for Q1 2023, filed 15 May 2023.